Aphria to "review" LATAM buy; shares down 10% premarket

|About: Aphria Inc. (APHA)|By:, SA News Editor

Cannabis outfit Aphria (NYSE:APHA) is down 10% premarket on increased volume on the heels of its announcement that it has appointed a special committee to review its recent acquisition of LATAM Holdings after short seller Quintessential Capital Management said the deal was largely worthless.

It is unclear exactly what the committee will review since the transaction was consummated only a couple months ago assuming, of course, that Aphria did its due diligence.

Previously: Aphria defends against short-seller report: Update (Dec. 4)

Subscribe for full text news in your inbox